Pinnacle Wealth Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AWA
Pinnacle Wealth Management Group's BMY Position: Q4 2022 in Review
Pinnacle Wealth Management Group sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 6,838 shares — an estimated $486K sold.
Pinnacle Wealth Management Group first reported a position in BMY in Q2 2021 and held it in 6 quarters. The position peaked at $512K in Q2 2022. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.
- Pinnacle Wealth Management Group reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
- Pinnacle Wealth Management Group sold 6,838 Bristol-Myers Squibb shares in Q4 2022, an estimated $486K.
- Pinnacle Wealth Management Group first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 6 quarters.
- Pinnacle Wealth Management Group's Bristol-Myers Squibb position peaked at $512K in Q2 2022.
- 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.
Based on Pinnacle Wealth Management Group's 13F filing for Q4 2022, filed 9 Jan 2023.